Hims & Hers Health shares jump on FDA's push to expand BPC-157 access
Tweet
Share
E-mail_6810ff306293b.jpg)
Get Alerts HIMS Hot Sheet
Join SI Premium – FREE
Investing.com -- Hims & Hers Health stock rose sharply during Thursday's midday trading session, climbing approximately 11%. The increase followed an FDA committee recommendation to expand access to the BPC-157 peptide.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades MR DIY Group M Bhd (MRDIY:MK) to Buy
- Hindustan Unilever Ltd (HUVR:IN) PT Lowered to INR2,165 at BofA Securities
- Canaccord Starts Kistos Holdings (KIST:LN) at Buy
Create E-mail Alert Related Categories
InvestingRelated Entities
Maynard Um, Mark Zuckerberg, FDA, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
